Heart defect mystery: can remote monitoring predict dangerous rhythms?

NCT ID NCT05122962

Recruiting now Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to understand why people with tetralogy of Fallot and other congenital heart diseases experience shortness of breath, palpitations, and changes in heart structure. Researchers will use remote heart rhythm monitors and imaging to track 300 participants over two years. The goal is to identify early warning signs of serious heart events, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better ways to detect and manage heart rhythm problems and exercise limitations in people with congenital heart disease.
What could go wrong: This is an observational study, not a treatment trial. It will not directly improve health, and results may take years to influence patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COARCTATION OF AORTA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aorta coarctation congenital heart disease congenitally corrected transposition of the great arteries Ebstein anomaly tetralogy of fallot transposition of the great arteries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONGENITAL HEART DISEASE TETRALOGY OF FALLOT

Contacts and locations

Locations

Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.